GlassScriptPhysician profile
Rajen Kanu Mehta
NPI 1457302879
$4,929.08
in general payments reported to CMS, 2019-2025
29 companies · $797 in 2025
The $797 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $335 · 2021: $565 · 2022: $504 · 2023: $665 · 2024: $890 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,352.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $705.68 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $526.72 | 2019-2025 | |
| Edwards Lifesciences Corporation | $517.76 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $483.92 | 2019-2022 | |
| Amgen INC. | $455.20 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $411.98 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Latitude Communicator Power Supply |
| Abiomed | $250.15 | 2023-2024 | Impella |
| Abbott Laboratories | $242.98 | 2019-2025 | Cardiomems |
| Medtronic, INC. | $199.98 | 2023-2025 | Selectsecure, Linq II, Azure Xt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $196.36 | 2022-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $163.47 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $149.81 | 2020-2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.06 | 2019-2025 | Lifevest |
| Pfizer INC. | $94.77 | 2022-2025 | |
| Stryker Corporation | $41.29 | 2025 | Limflow System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $38.39 | 2024 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $38.15 | 2019 | |
| Bracco Diagnostics INC. | $38.00 | 2021 | |
| Biotronik INC. | $37.76 | 2019 | |
| Bard Peripheral Vascular, INC. | $35.81 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.62 | 2023-2024 | Jardiance |
| Biosense Webster, INC. | $21.80 | 2025 | Nuvision Ice Catheter |
| Kiniksa Pharmaceuticals International, Plc | $19.23 | 2024 | Arcalyst |
| Azurity Pharmaceuticals, INC. | $17.12 | 2025 | Edarbi |
| Kiniksa Pharmaceuticals, LTD. | $16.80 | 2023 | Arcalyst |
| Medtronic Vascular, INC. | $16.60 | 2019 | |
| Amarin Pharma, INC. | $16.54 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $13.92 | 2024 | |
| Sanofi-Aventis U.S. LLC | $13.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajen Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.